These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 23040805)

  • 1. Dopaminergic modulation of synaptic transmission in cortex and striatum.
    Tritsch NX; Sabatini BL
    Neuron; 2012 Oct; 76(1):33-50. PubMed ID: 23040805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex.
    Xing B; Li YC; Gao WJ
    Brain Res; 2016 Jun; 1641(Pt B):217-33. PubMed ID: 26790349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic Modulation of Synaptic Plasticity, Its Role in Neuropsychiatric Disorders, and Its Computational Modeling.
    Madadi Asl M; Vahabie AH; Valizadeh A
    Basic Clin Neurosci; 2019; 10(1):1-12. PubMed ID: 31031889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F; Vaugeois JM; Petit M
    Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
    Rubi L; Fritschy JM
    J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-dopamine interaction: an overview.
    Esposito E; Di Matteo V; Di Giovanni G
    Prog Brain Res; 2008; 172():3-6. PubMed ID: 18772025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and the diseased brain.
    Kienast T; Heinz A
    CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):109-31. PubMed ID: 16613557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatodendritic dopamine release: recent mechanistic insights.
    Rice ME; Patel JC
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of striatal function and Parkinson's disease.
    Zhai S; Shen W; Graves SM; Surmeier DJ
    J Neural Transm (Vienna); 2019 Apr; 126(4):411-422. PubMed ID: 30937538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the subsecond dynamics of neurotransmission of dopamine and serotonin.
    Jennings KA
    ACS Chem Neurosci; 2013 May; 4(5):704-14. PubMed ID: 23627553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry.
    De Deurwaerdère P; Di Giovanni G; Millan MJ
    Prog Neurobiol; 2017 Apr; 151():57-100. PubMed ID: 27389773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex.
    Li YC; Kellendonk C; Simpson EH; Kandel ER; Gao WJ
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12107-12. PubMed ID: 21730148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson's disease.
    Mancini M; Calculli A; Di Martino D; Pisani A
    J Anesth Analg Crit Care; 2024 May; 4(1):33. PubMed ID: 38745258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.
    Centonze D; Gubellini P; Usiello A; Rossi S; Tscherter A; Bracci E; Erbs E; Tognazzi N; Bernardi G; Pisani A; Calabresi P; Borrelli E
    Neuroscience; 2004; 129(1):157-66. PubMed ID: 15489038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
    Calabresi P; Ghiglieri V; Mazzocchetti P; Corbelli I; Picconi B
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum.
    Mallet N; Delgado L; Chazalon M; Miguelez C; Baufreton J
    Cells; 2019 Aug; 8(9):. PubMed ID: 31470672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic dysfunction in Parkinson's disease.
    Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
    Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control.
    Speranza L; di Porzio U; Viggiano D; de Donato A; Volpicelli F
    Cells; 2021 Mar; 10(4):. PubMed ID: 33810328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.